Humana Inc. (NYSE:HUM) Shares Bought by Daymark Wealth Partners LLC

Daymark Wealth Partners LLC lifted its position in shares of Humana Inc. (NYSE:HUM) by 27.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,865 shares of the insurance provider’s stock after acquiring an additional 399 shares during the quarter. Daymark Wealth Partners LLC’s holdings in Humana were worth $591,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Pzena Investment Management LLC increased its position in Humana by 538.7% during the 2nd quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955,375 shares during the period. Ontario Teachers Pension Plan Board boosted its stake in shares of Humana by 11,647.2% in the first quarter. Ontario Teachers Pension Plan Board now owns 1,059,478 shares of the insurance provider’s stock valued at $367,342,000 after buying an additional 1,050,459 shares in the last quarter. Marshall Wace LLP grew its holdings in Humana by 118.9% during the second quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock worth $532,564,000 after acquiring an additional 774,085 shares during the period. Steadfast Capital Management LP purchased a new position in Humana in the first quarter worth $158,813,000. Finally, Allspring Global Investments Holdings LLC lifted its holdings in Humana by 255.4% in the first quarter. Allspring Global Investments Holdings LLC now owns 620,793 shares of the insurance provider’s stock valued at $215,241,000 after acquiring an additional 446,124 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the topic of a number of recent analyst reports. Morgan Stanley began coverage on shares of Humana in a research note on Monday, June 24th. They set an “equal weight” rating and a $374.00 price target on the stock. Truist Financial upped their target price on shares of Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a research report on Monday, July 15th. Royal Bank of Canada reduced their price target on shares of Humana from $400.00 to $265.00 and set an “outperform” rating for the company in a research report on Tuesday. Oppenheimer lowered their price target on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Finally, Jefferies Financial Group downgraded Humana from a “buy” rating to a “hold” rating and dropped their price objective for the company from $519.00 to $253.00 in a research note on Monday. One equities research analyst has rated the stock with a sell rating, eighteen have given a hold rating and six have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $322.00.

Humana Price Performance

HUM stock opened at $251.36 on Friday. The stock has a market capitalization of $30.29 billion, a price-to-earnings ratio of 15.65, a price-to-earnings-growth ratio of 2.44 and a beta of 0.50. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.70. Humana Inc. has a 52-week low of $213.31 and a 52-week high of $530.54. The stock’s fifty day simple moving average is $329.03 and its 200-day simple moving average is $341.40.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The firm had revenue of $29.54 billion for the quarter, compared to analyst estimates of $28.52 billion. During the same period last year, the company earned $8.94 EPS. The firm’s quarterly revenue was up 10.4% on a year-over-year basis. Equities research analysts expect that Humana Inc. will post 16.01 EPS for the current year.

Humana Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Investors of record on Monday, September 30th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.41%. The ex-dividend date is Monday, September 30th. Humana’s payout ratio is currently 22.04%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.